NL6618003A - - Google Patents

Info

Publication number
NL6618003A
NL6618003A NL6618003A NL6618003A NL6618003A NL 6618003 A NL6618003 A NL 6618003A NL 6618003 A NL6618003 A NL 6618003A NL 6618003 A NL6618003 A NL 6618003A NL 6618003 A NL6618003 A NL 6618003A
Authority
NL
Netherlands
Application number
NL6618003A
Other versions
NL139744B (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL6618003A publication Critical patent/NL6618003A/xx
Publication of NL139744B publication Critical patent/NL139744B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0031Rectum, anus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/02Suppositories; Bougies; Bases therefor; Ovules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
NL666618003A 1965-12-27 1966-12-22 Werkwijze ter bereiding van een therapeutisch preparaat voor de behandeling van stoornissen, veroorzaakt door onvoldoende afscheiding van het gele lichaam en vormstukken verkregen volgens deze werkwijze. NL139744B (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR75043815 1965-12-27

Publications (2)

Publication Number Publication Date
NL6618003A true NL6618003A (US07709020-20100504-C00041.png) 1967-06-28
NL139744B NL139744B (nl) 1973-09-17

Family

ID=9696042

Family Applications (1)

Application Number Title Priority Date Filing Date
NL666618003A NL139744B (nl) 1965-12-27 1966-12-22 Werkwijze ter bereiding van een therapeutisch preparaat voor de behandeling van stoornissen, veroorzaakt door onvoldoende afscheiding van het gele lichaam en vormstukken verkregen volgens deze werkwijze.

Country Status (5)

Country Link
US (1) US3557286A (US07709020-20100504-C00041.png)
BE (1) BE691600A (US07709020-20100504-C00041.png)
FR (1) FR5064M (US07709020-20100504-C00041.png)
GB (1) GB1127748A (US07709020-20100504-C00041.png)
NL (1) NL139744B (US07709020-20100504-C00041.png)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2675047B1 (fr) * 1991-04-09 1995-05-12 Theramex Nouvelles compositions pharmaceutiques anti-glaucomateuses et leur procede d'obtention.

Also Published As

Publication number Publication date
GB1127748A (en) 1968-09-18
US3557286A (en) 1971-01-19
NL139744B (nl) 1973-09-17
BE691600A (US07709020-20100504-C00041.png) 1967-06-22
FR5064M (US07709020-20100504-C00041.png) 1967-05-08

Similar Documents

Publication Publication Date Title
JPS4112238Y1 (US07709020-20100504-C00041.png)
JPS4319136Y1 (US07709020-20100504-C00041.png)
BE675324A (US07709020-20100504-C00041.png)
JPS419073Y1 (US07709020-20100504-C00041.png)
JPS424519Y1 (US07709020-20100504-C00041.png)
JPS437434Y1 (US07709020-20100504-C00041.png)
JPS451008Y1 (US07709020-20100504-C00041.png)
JPS4512072Y1 (US07709020-20100504-C00041.png)
JPS4822758B1 (US07709020-20100504-C00041.png)
JPS4328872Y1 (US07709020-20100504-C00041.png)
JPS453902Y1 (US07709020-20100504-C00041.png)
BE676004A (US07709020-20100504-C00041.png)
BE675830A (US07709020-20100504-C00041.png)
BE673393A (US07709020-20100504-C00041.png)
NL135331C (US07709020-20100504-C00041.png)
NL6510369A (US07709020-20100504-C00041.png)
NL6602107A (US07709020-20100504-C00041.png)
BE672809A (US07709020-20100504-C00041.png)
BE673203A (US07709020-20100504-C00041.png)
NL6604234A (US07709020-20100504-C00041.png)
BE673306A (US07709020-20100504-C00041.png)
NL6610951A (US07709020-20100504-C00041.png)
NL6615363A (US07709020-20100504-C00041.png)
BE690255A (US07709020-20100504-C00041.png)
BE675420A (US07709020-20100504-C00041.png)

Legal Events

Date Code Title Description
NL80 Abbreviated name of patent owner mentioned of already nullified patent

Owner name: ROUSSEL UCLAF

V4 Discontinued because of reaching the maximum lifetime of a patent